Position in BMY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$938,820,116
+$291,617,722 QoQ
Shares Held
16,293,303
+52.7% QoQ
Ownership
0.798%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#23
of 2,514 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 61%
Shared 0%
None 39%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FMR LLC holds $75,393,052,380 across 17 Drug Manufacturers - General names. BMY ranks #10 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
28,462,475 | $34,138,749,234 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
66,870,816 | $8,448,458,890 | |
| 3 | MRK |
Merck & Co., Inc.
|
45,440,355 | $5,839,085,616 | |
| 4 | JNJ |
Johnson & Johnson
|
22,595,566 | $5,738,595,894 | |
| 5 | AZN |
Astrazeneca PLC
|
28,895,264 | $5,479,119,956 | |
| 6 | ABBV |
AbbVie Inc.
|
20,773,786 | $5,227,515,506 | |
| 7 | BIIB |
Biogen Inc.
|
18,217,239 | $3,936,016,655 | |
| 8 | GSK |
GSK plc
|
64,961,641 | $3,405,289,219 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $938,820,116 | 16,293,303 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $647,202,394 | 10,671,103 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $552,901,504 | 10,250,306 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $464,492,115 | 10,299,160 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $751,201,894 | 16,228,168 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,318,690,770 | 21,621,426 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $1,759,627,919 | 31,110,819 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $2,325,227,106 | 44,940,609 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,688,810,053 | 40,664,822 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $2,308,310,900 | 42,565,202 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $2,186,445,627 | 42,612,466 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $2,496,932,627 | 43,020,893 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,989,366,473 | 46,745,371 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $3,417,302,031 | 49,304,603 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $4,253,073,430 | 59,111,514 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $4,969,211,187 | 69,900,284 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $5,534,947,572 | 71,882,436 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $4,895,001,306 | 67,027,267 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $3,524,345,469 | 56,525,188 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,633,296,393 | 61,404,367 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $4,575,557,096 | 68,475,862 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $3,759,789,216 | 59,556,300 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $3,675,947,234 | 59,260,797 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $3,775,723,045 | 62,626,025 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $3,856,287,512 | 65,583,121 | Shares | Defined | 2020-08-24 | |
| 2020-03-31 | $3,846,138,702 | 69,001,412 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||